![](/img/cover-not-exists.png)
Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer
Drew, Yvette, Ledermann, Jonathan, Hall, Geoff, Rea, Daniel, Glasspool, Ros, Highley, Martin, Jayson, Gordon, Sludden, Julieann, Murray, James, Jamieson, David, Halford, Sarah, Acton, Gary, Backholer,Volume:
114
Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/bjc.2016.133
Date:
June, 2016
File:
PDF, 103 KB
english, 2016